Healthcare -
Biotechnology - NASDAQ - US
$ 36.91
0.819 %
$ 3.49 B
Market Cap
-6.33
P/E
RARE - CASH & EQUIVALENTS
Cash & Equivalents RARE - Ultragenyx Pharmaceutical Inc.
174 M
LAST VALUE
14.31%
2 YEAR CAGR
-16.72%
5 YEAR CAGR
21.73%
10 YEAR CAGR